Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System. - Kory Kreimeyer; Oanh Dang; Jonathan Spiker; Monica A. Muñoz; Gary Rosner; Robert Ball; Taxiarchis Botsis (Comput. Biol. Medicine, 2021)

Challenges and opportunities for mining adverse drug reactions: perspectives from pharma, regulatory agencies, healthcare providers and consumers. - Graciela Gonzalez-Hernandez; Martin Krallinger; Monica A. Muñoz; Raul Rodriguez-Esteban; Özlem Uzuner; Lynette Hirschman (Database J. Biol. Databases Curation, 2022)